RGD
RGD is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to integrins.
Product Specifications
CAS Number
[99896-85-2]
UNSPSC
12352209
Hazard Statement
H315, H319, H335
Target
Integrin
Type
Peptides
Related Pathways
Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/RGD.html
Purity
99.60
Solubility
DMSO : 1.94 mg/mL (ultrasonic; adjust pH to 3 with HCl) |H2O : 10 mg/mL (ultrasonic)
Smiles
O=C(O)C[C@@H](C(O)=O)NC(CNC([C@H](CCCNC(N)=N)N)=O)=O
Molecular Formula
C12H22N6O6
Molecular Weight
346.34
Precautions
H315, H319, H335
References & Citations
[1]Hersel U, et al. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 2003 Nov;24 (24) :4385-415.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported
Citation 01
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Bromodeoxyuridine (Bromodeoxyuridine, BUdr, BrdU) (BSA & Azide Free) (MaxLight 650)
Bromodeoxyuridine (Bromodeoxyuridine, BUdr, BrdU) (BSA & Azide Free) (MaxLight 650)
Rad9, Phosphorylated (Tyr28) (RAD9A, Cell Cycle Checkpoint Control Protein RAD9A, hRAD9, DNA Repair Exonuclease Rad9 Homolog A) (AP)
Rad9, Phosphorylated (Tyr28) (RAD9A, Cell Cycle Checkpoint Control Protein RAD9A, hRAD9, DNA Repair Exonuclease Rad9 Homolog A) (AP)
